Instead, regarding the CD8+ T-cell proliferative response (Figure 2B) at the early time point, post-COVID-19 patients with pneumonia developed higher levels than patients with mild symptoms (p < 0.001) and vaccinated subjects (p < 0.05). This evidence concerns the gene CD8A and susceptibility to pneumonia measurement.